Bogdanowicz G, Kwieciński R
Oddziału Nefrologicznego i Ośrodka Dializ Wojewódzkiego Szpitala Zespolonego w Opolu.
Wiad Lek. 1990;43(17-18):853-7.
The studied group comprised 10 patients with chronic renal failure on a programme of extracorporeal haemodialyses continued since 4 to 52 months, in whom the haematocrit value obtained during monthly laboratory investigations was below 21%, and who required at least one blood transfusion in three months. Before the study, after 3 months of treatment with vitamin E 600 mg in 24 hours, and 3 months after the completion of this treatment the following parameters were analysed: haemoglobin level, erythrocyte count, volume of blood transfused in various periods of the treatment. A slight rise of haematocrit value, haemoglobin level and erythrocyte count was observed after vitamin E treatment, but this rise was not significant statistically. No effect of vitamin E was noted on the osmotic resistance of the erythrocytes and the amount of blood transfused in the observed time periods. No side effects of vitamin E were noted.
研究组包括10例慢性肾衰竭患者,他们接受体外血液透析治疗已持续4至52个月,每月实验室检查时测得的血细胞比容值低于21%,且在三个月内至少需要输血一次。在研究前、接受24小时600毫克维生素E治疗3个月后以及该治疗结束3个月后,对以下参数进行了分析:血红蛋白水平、红细胞计数、治疗各阶段的输血量。维生素E治疗后,血细胞比容值、血红蛋白水平和红细胞计数略有上升,但在统计学上无显著意义。未观察到维生素E对红细胞渗透抵抗力及观察时间段内输血量有影响。未发现维生素E有副作用。